VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Monday, December 29, 2025
Stock Comparison
BAE Systems plc vs Novo Nordisk A/S
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
BAE Systems plc
BA. · London Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into BAE Systems plc's moat claims, evidence, and risks.
View BA. analysisNovo Nordisk A/S
NOVOB · Nasdaq Copenhagen
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Novo Nordisk A/S's moat claims, evidence, and risks.
View NOVOB analysisComparison highlights
- Moat score gap: Novo Nordisk A/S leads (85 / 100 vs 75 / 100 for BAE Systems plc).
- Segment focus: BAE Systems plc has 5 segments (26.6% in Electronic Systems); Novo Nordisk A/S has 3 segments (71.1% in Diabetes care).
- Moat breadth: BAE Systems plc has 8 moat types across 3 domains; Novo Nordisk A/S has 5 across 3.
Primary market context
BAE Systems plc
Electronic Systems
Defence electronics (electronic warfare, avionics, C4ISR, space payloads and mission systems)
Primarily US and UK; global programmes
Government defence and intelligence agencies; prime contractors
Subsystem OEM and prime contractor for electronics/mission systems
26.6%
Novo Nordisk A/S
Diabetes care
Diabetes pharmaceuticals (GLP-1 for type 2 diabetes, insulin, and related therapies)
Global
Payers/providers and patients (via wholesalers/pharmacies/hospitals)
Originator pharma (R&D, regulatory, manufacturing, commercialization)
71.1%
Side-by-side metrics
Moat coverage
Shared moat types
BAE Systems plc strengths
Novo Nordisk A/S strengths
Segment mix
BAE Systems plc segments
Full profile >Electronic Systems
Oligopoly
Platforms & Services
Oligopoly
Air
Oligopoly
Maritime
Oligopoly
Cyber & Intelligence
Competitive
Novo Nordisk A/S segments
Full profile >Diabetes care
Oligopoly
Obesity care
Duopoly
Rare disease
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.